Park Ha Biological Technology is trading 7.5% down at $2.21 in pre-market on October 21, 2026, and the decline remains unexplained.
- Searches found no fresh company announcement or filing; the latest filings surfaced were from September, and the press-release page showed older news.
- Biotech was indicated higher, while major-index moves were mixed.